Compare

CRH/$CRH

1D1W1M3M6MYTD1Y5YMAX

About CRH

CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.
Ticker
$CRH
Sector
Materials
Primary listing
NYSE
Employees
83,032
Headquarters
Dublin, Ireland

CRH Metrics

BasicAdvanced
$55B
14.51
$5.67
1.20
$1.35
1.90%

What the Analysts think about CRH

Analyst ratings (Buy, Hold, Sell) for CRH stock.
Analyst projections of the future price of CRH stock.

Bulls say / Bears say

Second-quarter revenue rose 6% and adjusted EBITDA rose 7% year on year, with the EBITDA margin improving to 24.4%. The result shows CRH continued to grow profits and protect margins despite inflation. (CRH)
CRH says transport and water infrastructure spending, alongside stronger data-centre and advanced-manufacturing projects, is supporting demand across its markets. That mix could help sustain growth even while parts of housing remain weak. (The Motley Fool)
The planned $8.5bn Arcosa acquisition would add aggregates capacity in growing US markets and expand CRH’s infrastructure offering. CRH expects the deal to add to earnings, margins and cash flow in its first year after completion, with $175m of annual run-rate cost synergies by year three. (CRH)
US new-build housing remains subdued, and Americas Building Solutions’ adjusted EBITDA fell 8% in the second quarter. Continued weakness in homebuilding could keep pressure on this part of CRH’s business. (The Motley Fool)
Higher haulage rates raised costs in Americas Building Solutions and weighed on segment profitability. Price surcharges and cost reductions may take time to recover those costs. (The Motley Fool)
The $8.5bn Arcosa deal commits substantial capital, and Morningstar says the acquisition adds cyclicality and has lowered its valuation for CRH. The expected returns therefore depend in part on integrating Arcosa and delivering the planned synergies. (Morningstar, CRH)
Data summarised monthly by Lightyear AI. Last updated on 13 Oct 2026.

CRH Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

CRH Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing CRH

AllEURGBPUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.